Pharmaceuticals

Breast Cancer Therapeutics Market was valued at US$ 31,073.52 Million in 2022 and is expected to reach US$ 63,967.05 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Breast Cancer Therapeutics Market was valued at US$ 31,073.52 Million in 2022 and is expected to reach US$ 63,967.05 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

Market News Insights December 24, 2024

Asia Pacific is the fastest-growing region in the global breast cancer therapeutics market. North America accounted for...

Read More Read more about Breast Cancer Therapeutics Market was valued at US$ 31,073.52 Million in 2022 and is expected to reach US$ 63,967.05 Million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030

Fish Vaccine Market was valued at US$ 355.88 Million in 2022 and is expected to reach US$ 617.38 Million by 2030; it is estimated to record a CAGR of 7.1% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Fish Vaccine Market was valued at US$ 355.88 Million in 2022 and is expected to reach US$ 617.38 Million by 2030; it is estimated to record a CAGR of 7.1% from 2022 to 2030

Market News Insights December 23, 2024

Increasing Government Initiatives Fuel Fish Vaccine Market Growth Aquaculture grows exponentially due to the high demand for...

Read More Read more about Fish Vaccine Market was valued at US$ 355.88 Million in 2022 and is expected to reach US$ 617.38 Million by 2030; it is estimated to record a CAGR of 7.1% from 2022 to 2030

Poultry Vaccines Market was valued at US$ 2.1 Billion in 2023 and is expected to reach US$ 4.1 Billion by 2031; it is estimated to record a CAGR of 8.6% from 2023 to 2031

• Life Sciences
• Pharmaceuticals

Poultry Vaccines Market was valued at US$ 2.1 Billion in 2023 and is expected to reach US$ 4.1 Billion by 2031; it is estimated to record a CAGR of 8.6% from 2023 to 2031

Market News Insights December 20, 2024

Rising Prevalence of Poultry Diseases     Poultry production results in producing different types of animal proteins through...

Read More Read more about Poultry Vaccines Market was valued at US$ 2.1 Billion in 2023 and is expected to reach US$ 4.1 Billion by 2031; it is estimated to record a CAGR of 8.6% from 2023 to 2031

Stomach Cancer Market was valued at US$ 3,575.04 Million in 2022 and is expected to reach to US$ 10,751.42 Million by 2030; it is estimated to record a CAGR of 14.8% from 2022 to 2030

• Pharmaceuticals

Stomach Cancer Market was valued at US$ 3,575.04 Million in 2022 and is expected to reach to US$ 10,751.42 Million by 2030; it is estimated to record a CAGR of 14.8% from 2022 to 2030

Market News Insights December 19, 2024

Stomach cancer or gastric cancer is a type of malignant cancer that spreads on the stomach’s inner...

Read More Read more about Stomach Cancer Market was valued at US$ 3,575.04 Million in 2022 and is expected to reach to US$ 10,751.42 Million by 2030; it is estimated to record a CAGR of 14.8% from 2022 to 2030

Eye Drops Market was valued at US$ 15,793.27 Million in 2022 and is expected to reach US$ 23,788.45 Million by 2030; it is estimated to record a CAGR of 5.3% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

Eye Drops Market was valued at US$ 15,793.27 Million in 2022 and is expected to reach US$ 23,788.45 Million by 2030; it is estimated to record a CAGR of 5.3% from 2022 to 2030

Market News Insights December 18, 2024

The report highlights trends prevailing in the market and the factors driving and hindering the eye drops...

Read More Read more about Eye Drops Market was valued at US$ 15,793.27 Million in 2022 and is expected to reach US$ 23,788.45 Million by 2030; it is estimated to record a CAGR of 5.3% from 2022 to 2030

Infectious Disease Therapeutics Market was valued at US$ 1,19,708.77 Million in 2022 and is expected to reach to US$ 1,67,883.93 Million by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030

• Pharmaceuticals

Infectious Disease Therapeutics Market was valued at US$ 1,19,708.77 Million in 2022 and is expected to reach to US$ 1,67,883.93 Million by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030

Market News Insights December 13, 2024

Increasing Focus on Funding and R&D in Infectious Disease Therapeutics Drives Infectious Disease Therapeutics Market Research and...

Read More Read more about Infectious Disease Therapeutics Market was valued at US$ 1,19,708.77 Million in 2022 and is expected to reach to US$ 1,67,883.93 Million by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030

Respiratory Tract Infection Treatment Market was valued at US$ 43.60 Billion in 2023 and is expected to reach to US$ 69.13 Billion by 2031; it is estimated to record a CAGR of 5.93% from 2023 to 2031

• Pharmaceuticals

Respiratory Tract Infection Treatment Market was valued at US$ 43.60 Billion in 2023 and is expected to reach to US$ 69.13 Billion by 2031; it is estimated to record a CAGR of 5.93% from 2023 to 2031

Market News Insights December 13, 2024

Increasing Prevalence of Respiratory Disorders Drives Global Respiratory Tract Infection Treatment Market Growth In recent years, there...

Read More Read more about Respiratory Tract Infection Treatment Market was valued at US$ 43.60 Billion in 2023 and is expected to reach to US$ 69.13 Billion by 2031; it is estimated to record a CAGR of 5.93% from 2023 to 2031

Osteoporosis Treatment Market was valued at US$ 16.83 Billion in 2023 and is expected to reach to US$ 22.72 Billion by 2031; it is estimated to record a CAGR of 3.8% from 2023 to 2031

• Pharmaceuticals

Osteoporosis Treatment Market was valued at US$ 16.83 Billion in 2023 and is expected to reach to US$ 22.72 Billion by 2031; it is estimated to record a CAGR of 3.8% from 2023 to 2031

Market News Insights December 12, 2024

The osteoporosis treatment market includes various drugs and therapeutic modalities carefully developed to combat osteoporosis—a disease characterized...

Read More Read more about Osteoporosis Treatment Market was valued at US$ 16.83 Billion in 2023 and is expected to reach to US$ 22.72 Billion by 2031; it is estimated to record a CAGR of 3.8% from 2023 to 2031

India Lymphedema Treatment Market was valued at US$ 926.65 Million in 2022 and is expected to reach US$ 1,511.06 Million by 2030; it is estimated to record a CAGR of 12.39% from 2022 to 2030

• Life Sciences
• Pharmaceuticals

India Lymphedema Treatment Market was valued at US$ 926.65 Million in 2022 and is expected to reach US$ 1,511.06 Million by 2030; it is estimated to record a CAGR of 12.39% from 2022 to 2030

Market News Insights December 10, 2024

Growing Involvement of Public and Private Entities to Treat Lymphedema to Offer Opportunities for India Lymphedema Treatment...

Read More Read more about India Lymphedema Treatment Market was valued at US$ 926.65 Million in 2022 and is expected to reach US$ 1,511.06 Million by 2030; it is estimated to record a CAGR of 12.39% from 2022 to 2030

Transmucosal Drug Delivery Systems Market was valued at US$ 80.21 Billion in 2023 and is expected to reach to US$ 129.46 Billion by 2031; it is estimated to record a CAGR of 6.2% from 2023 to 2031

• Pharmaceuticals

Transmucosal Drug Delivery Systems Market was valued at US$ 80.21 Billion in 2023 and is expected to reach to US$ 129.46 Billion by 2031; it is estimated to record a CAGR of 6.2% from 2023 to 2031

Market News Insights December 10, 2024

Based on geography, the transmucosal drug delivery systems market is segmented into North America, Asia Pacific, Europe,...

Read More Read more about Transmucosal Drug Delivery Systems Market was valued at US$ 80.21 Billion in 2023 and is expected to reach to US$ 129.46 Billion by 2031; it is estimated to record a CAGR of 6.2% from 2023 to 2031